The Potential of FOXP3 in Predicting Survival and Treatment Response in Breast Cancer
Luyao Liu,1 Wang Xiao,2 Chaojie Zhang,1 Peizhi Fan,1 Jie Zeng,1 Jianing Yi1 1Department of Breast and Thyroid Surgery, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, People’s Republic of China; 2Department of General Surgery, The Second Xiangy...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-03-01
|
| Series: | International Journal of General Medicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/the-potential-of-foxp3-in-predicting-survival-and-treatment-response-i-peer-reviewed-fulltext-article-IJGM |
| _version_ | 1797231325184262144 |
|---|---|
| author | Liu L Xiao W Zhang C Fan P Zeng J Yi J |
| author_facet | Liu L Xiao W Zhang C Fan P Zeng J Yi J |
| author_sort | Liu L |
| collection | DOAJ |
| description | Luyao Liu,1 Wang Xiao,2 Chaojie Zhang,1 Peizhi Fan,1 Jie Zeng,1 Jianing Yi1 1Department of Breast and Thyroid Surgery, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, People’s Republic of China; 2Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, People’s Republic of ChinaCorrespondence: Jianing Yi; Jie Zeng, Department of Breast and Thyroid Surgery, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, 61 Jiefang West Road, Changsha, Hunan, 410005, People’s Republic of China, Tel +8613007436234 ; +8613974837749, Email yijianing@hunnu.edu.cn; zengjie227@hunnu.edu.cnBackground: Breast cancer (BC) continues to pose a substantial challenge to global health, necessitating an enhanced understanding of its fundamental mechanisms. Among its various pathological classifications, breast invasive carcinoma (BRCA) is the most prevalent. The role of the transcription factor forkhead box P3 (FOXP3), associated with regulatory T cells, in BRCA’s diagnosis and prognosis remains insufficiently explored, despite its recognized importance.Methods: We examined the mRNA expression profile of FOXP3 in BRCA patients, assessing its correlation with disease detection, patient survival, immune checkpoint alterations, and response to anticancer drugs.Results: Our analysis revealed significantly elevated FOXP3 mRNA levels in BRCA patients, with a 95.7% accuracy for BRCA detection based on the area under the curve. High FOXP3 mRNA levels were positively correlated with overall survival and showed significant associations with CTLA4, CD274, PDCD1, TMB, and immune cell infiltration status. Furthermore, FOXP3 mRNA expression was linked to the efficacy of anticancer drugs and the tumor inflammation signature.Discussion: These findings suggest that FOXP3 serves as a promising biomarker for BRCA, offering valuable insights into its diagnosis and prognosis. The correlation between FOXP3 expression and immune checkpoint alterations, along with its predictive value for treatment response, underscores its potential in guiding therapeutic strategies.Conclusion: FOXP3 stands out as an influential factor in BRCA, highlighting its diagnostic accuracy and prognostic value. Its association with immune responses and treatment efficacy opens new avenues for research and clinical applications, positioning FOXP3 as a vital target for further investigation in BRCA management.Keywords: breast cancer, FOXP3, regulatory T cells, immune checkpoint alterations, anticancer drugs response, immune cell infiltration |
| first_indexed | 2024-04-24T15:42:35Z |
| format | Article |
| id | doaj.art-3b0c349563f2466d92512a64282f9e5c |
| institution | Directory Open Access Journal |
| issn | 1178-7074 |
| language | English |
| last_indexed | 2024-04-24T15:42:35Z |
| publishDate | 2024-03-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | International Journal of General Medicine |
| spelling | doaj.art-3b0c349563f2466d92512a64282f9e5c2024-04-01T18:03:49ZengDove Medical PressInternational Journal of General Medicine1178-70742024-03-01Volume 171233125191604The Potential of FOXP3 in Predicting Survival and Treatment Response in Breast CancerLiu LXiao WZhang CFan PZeng JYi JLuyao Liu,1 Wang Xiao,2 Chaojie Zhang,1 Peizhi Fan,1 Jie Zeng,1 Jianing Yi1 1Department of Breast and Thyroid Surgery, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, People’s Republic of China; 2Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, People’s Republic of ChinaCorrespondence: Jianing Yi; Jie Zeng, Department of Breast and Thyroid Surgery, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, 61 Jiefang West Road, Changsha, Hunan, 410005, People’s Republic of China, Tel +8613007436234 ; +8613974837749, Email yijianing@hunnu.edu.cn; zengjie227@hunnu.edu.cnBackground: Breast cancer (BC) continues to pose a substantial challenge to global health, necessitating an enhanced understanding of its fundamental mechanisms. Among its various pathological classifications, breast invasive carcinoma (BRCA) is the most prevalent. The role of the transcription factor forkhead box P3 (FOXP3), associated with regulatory T cells, in BRCA’s diagnosis and prognosis remains insufficiently explored, despite its recognized importance.Methods: We examined the mRNA expression profile of FOXP3 in BRCA patients, assessing its correlation with disease detection, patient survival, immune checkpoint alterations, and response to anticancer drugs.Results: Our analysis revealed significantly elevated FOXP3 mRNA levels in BRCA patients, with a 95.7% accuracy for BRCA detection based on the area under the curve. High FOXP3 mRNA levels were positively correlated with overall survival and showed significant associations with CTLA4, CD274, PDCD1, TMB, and immune cell infiltration status. Furthermore, FOXP3 mRNA expression was linked to the efficacy of anticancer drugs and the tumor inflammation signature.Discussion: These findings suggest that FOXP3 serves as a promising biomarker for BRCA, offering valuable insights into its diagnosis and prognosis. The correlation between FOXP3 expression and immune checkpoint alterations, along with its predictive value for treatment response, underscores its potential in guiding therapeutic strategies.Conclusion: FOXP3 stands out as an influential factor in BRCA, highlighting its diagnostic accuracy and prognostic value. Its association with immune responses and treatment efficacy opens new avenues for research and clinical applications, positioning FOXP3 as a vital target for further investigation in BRCA management.Keywords: breast cancer, FOXP3, regulatory T cells, immune checkpoint alterations, anticancer drugs response, immune cell infiltrationhttps://www.dovepress.com/the-potential-of-foxp3-in-predicting-survival-and-treatment-response-i-peer-reviewed-fulltext-article-IJGMbreast cancerfoxp3regulatory t cellsimmune checkpoint alterationsanticancer drugs responseimmune cell infiltration |
| spellingShingle | Liu L Xiao W Zhang C Fan P Zeng J Yi J The Potential of FOXP3 in Predicting Survival and Treatment Response in Breast Cancer International Journal of General Medicine breast cancer foxp3 regulatory t cells immune checkpoint alterations anticancer drugs response immune cell infiltration |
| title | The Potential of FOXP3 in Predicting Survival and Treatment Response in Breast Cancer |
| title_full | The Potential of FOXP3 in Predicting Survival and Treatment Response in Breast Cancer |
| title_fullStr | The Potential of FOXP3 in Predicting Survival and Treatment Response in Breast Cancer |
| title_full_unstemmed | The Potential of FOXP3 in Predicting Survival and Treatment Response in Breast Cancer |
| title_short | The Potential of FOXP3 in Predicting Survival and Treatment Response in Breast Cancer |
| title_sort | potential of foxp3 in predicting survival and treatment response in breast cancer |
| topic | breast cancer foxp3 regulatory t cells immune checkpoint alterations anticancer drugs response immune cell infiltration |
| url | https://www.dovepress.com/the-potential-of-foxp3-in-predicting-survival-and-treatment-response-i-peer-reviewed-fulltext-article-IJGM |
| work_keys_str_mv | AT liul thepotentialoffoxp3inpredictingsurvivalandtreatmentresponseinbreastcancer AT xiaow thepotentialoffoxp3inpredictingsurvivalandtreatmentresponseinbreastcancer AT zhangc thepotentialoffoxp3inpredictingsurvivalandtreatmentresponseinbreastcancer AT fanp thepotentialoffoxp3inpredictingsurvivalandtreatmentresponseinbreastcancer AT zengj thepotentialoffoxp3inpredictingsurvivalandtreatmentresponseinbreastcancer AT yij thepotentialoffoxp3inpredictingsurvivalandtreatmentresponseinbreastcancer AT liul potentialoffoxp3inpredictingsurvivalandtreatmentresponseinbreastcancer AT xiaow potentialoffoxp3inpredictingsurvivalandtreatmentresponseinbreastcancer AT zhangc potentialoffoxp3inpredictingsurvivalandtreatmentresponseinbreastcancer AT fanp potentialoffoxp3inpredictingsurvivalandtreatmentresponseinbreastcancer AT zengj potentialoffoxp3inpredictingsurvivalandtreatmentresponseinbreastcancer AT yij potentialoffoxp3inpredictingsurvivalandtreatmentresponseinbreastcancer |